ANDREW R.L. McNAUGHTON was born on July 21, 1916, in Guilford, England. He was the eldest of 5 children. His personality and character were molded by the dominating presence of his father, General A.G.L. McNaughton, the commander of the Canadian Armed Forces. His father was primarily a Scientist and President of the Canadian National Research Council. With this distinguished family background, Andrew's education included Classical Studies under the Jesuits at Loyola College in Montreal, Electrical Engineering at Canadian Royal Military College and Geology and Mining at McGill University. Already an accomplished pilot when World War II began, Andrew joined the Air Force. With a basic liking for risky behind-the-scenes adventures Andrew rose to become the Chief Test Pilot for the Canadian Air Force. He was awarded the Air Force Cross for this crucial and dangerous assignment. By war's end he was experienced and certified to fly at the controls of 77 different aircraft. Growing up in a family where his father's guests were some of the biggest names in science, Andrew had often heard complaints of scientists not getting a hearing from their peers. New ideas and innovative technology often went begging for want of funding for their development due to the control of the medical/drug industry. In the early 1950's, Andrew created The McNaughton Foundation as a vehicle for "Sponsoring Independent Research" to advance ideas contrary to prevailing scientific opinion. Among its early projects were the pilot study on the computerization of the medical library at the Royal Society of Medicine, London, environmental and agricultural betterment projects and the study of factors contributing to the achievement and maintenance of physical and mental health. Later projects focused on transport minerals, aging, heart disease, diabetes and cancer detection, prevention and control. As an experienced General Consultant specializing in International Affairs, Andrew McNaughton was a valued advisor serving 38 clients. In 1956, he was introduced to Laetrile Pioneer, Biochemist Ernst Krebs, Jr. In the course of 3 days of discussions, Andrew came to the position of guaranteeing his support for Laetrile as the most promising approach to the solution to the riddle of cancer. Andrew turned to his native Canada to get clinical studies underway. He enlisted the talents of the McNaughton Foundation Board Member, Stephen Zalac, to set up Laetrile extraction laboratories and make contact with eminent Canadian physicians and hospitals. The initial studies proved successful. This encouraged support from the Canadian FDA and financial contributions from individuals and the government of the Province of Quebec. The medical facilities expanded with increasing numbers of Canadian and American cancer patients. Opposition from the American cancer establishment mobilized to bring pressure from the Unites States FDA. A sudden change of attitude from the Canadian FDA resulted in a shut-down of the Laetrile testing program in spite of testimony of Laetrile's effectiveness by prominent physicians. As a consequence, Andrew moved the operations of the Foundation to the United States. A master of diplomacy, Andrew developed friendly contacts with FDA officials and began the laborious process of developing the New Drug Application presentation of Laetrile's anti-cancer properties. Technical data and animal tests supplemented the expanding record of cancer patients using Laetrile. Andrew's idealism coupled with his scientific discipline enabled him to obtain funding as well as successfully guide the development of the factual data. Scientists and physicians were recruited to anonymously write the presentations. Each section of the 1,000 page New Drug Application was submitted for prior review to the friendly guidance of some FDA officials, who also aided the effort in relative anonymity. In early 1970, the volume was completed and submitted. The FDA termed it "the most superior submission for approval ever received." The FDA issued the permit IND #6734 on May 21, 1970, allowing the McNaughton Foundation to proceed with Phase I Clinical Trials. Through chicanery similar to what occurred in Canada 10 years previously the IND #6734 was abruptly withdrawn. In the face of these setbacks to Laetrile acceptance, and the personal tragedy of the unexpected death of his young wife Jacqueline, Andrew McNaughton paused with stoic equanimity. Then with renewed vigor he set a new course. Steve Zalac was brought to Mexico to assist the setting up of Laetrile extraction facilities and the organization of clinics. The Foundation also went out to The People with publicity and Conventions. Successfully treated Laetrile patient Cecile Hofman had been encouraged by Andrew to organize an association of patients, which she named The International Association of Cancer Victims & Friends (IACVF). This was the fore-runner of the Cancer Control Society. Other groups such as the Committee for Freedom of Choice also joined in the efforts to publicize Laetrile. Dr. Dean Burk, a Founding Scientist and Head of the Cytochemistry Department of the National Cancer Institute, responded to Andrew's presentation of the science behind Laetrile's effectiveness against cancer, and took the lead in the public spotlight. This helped other Alternative Therapies come into existence. In 1972, a major project under Andrew's thoughtful guidance got underway to gain the attention of the United States Federal Courts to stop the government agencies from harassing cancer patients and seizing their Laetrile supplies as they returned from the Mexican clinics. In 1976, Judge Luther Bohanon presiding in the Federal Court in Oklahoma City issued Protective Orders granting cancer patients the right to bring their Laetrile supplies from Mexico. The Order forbade the U.S. Customs and Department of HEW (including the FDA) from interfering with patients and their supplies in any way. Andrew McNaughton's life and personality may be best described as an adventurous risk-taker, driven by an idealism to serve a higher cause… a dream just within reach. We stand at the end of an era and a new beginning. With Andrew McNaughton's passing over a year ago it is in recognition of his leadership and idealism that we present this Humanitarian Award to his life-long friend and confidante, Michel Casseltine.


Or for ordering information, click on To order

Return to Home Page.